. . . . . . . . . . . . "a(SCHEM:\"trans10,cis12-Octadecadienoate\") -> p(HGNC:ELK1,pmod(P))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Stromal vascular cultures containing newly differentiated human adipocytes were pretreated with a vehicle (dimethyl sulfoxide) for 1 hour, then with 1 microM BRL49653 (PPARgamma agonist) for 24hours and subsequently treated with 30microM trans-10, cis-12 conjugated linoleic acid for an additional 24hours. CLA treatment conferred the ability of ERK1/2 to phosphorylate its nuclear substrate ELK1 in vitro. Pretreatment with BRL49653 blocked the CLA mediated ability of ERK1/2 to phosphorylate ELK-1" . . "Selventa" . . . . "2014-07-03T14:30:22.285+02:00"^^ . . .